These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

278 related articles for article (PubMed ID: 12522843)

  • 21. Very early treatment with infliximab in addition to methotrexate in early, poor-prognosis rheumatoid arthritis reduces magnetic resonance imaging evidence of synovitis and damage, with sustained benefit after infliximab withdrawal: results from a twelve-month randomized, double-blind, placebo-controlled trial.
    Quinn MA; Conaghan PG; O'Connor PJ; Karim Z; Greenstein A; Brown A; Brown C; Fraser A; Jarret S; Emery P
    Arthritis Rheum; 2005 Jan; 52(1):27-35. PubMed ID: 15641102
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methotrexate pneumonitis in a patient with rheumatoid arthritis.
    Hsu PC; Lan JL; Hsieh TY; Jan YJ; Huang WN
    J Microbiol Immunol Infect; 2003 Jun; 36(2):137-40. PubMed ID: 12886966
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Interstitial pneumonitis and anti-tumor necrosis factor-alpha therapy.
    Roos JC; Chilvers ER; Ostor AJ
    J Rheumatol; 2007 Jan; 34(1):238-9; author reply 239. PubMed ID: 17216703
    [No Abstract]   [Full Text] [Related]  

  • 24. Infliximab treatment of rheumatoid arthritis.
    Maini SR
    Rheum Dis Clin North Am; 2004 May; 30(2):329-47, vii. PubMed ID: 15172044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clinical efficacy of infliximab plus methotrexate in DMARD naive and DMARD refractory rheumatoid arthritis is associated with decreased synovial expression of TNF alpha and IL18 but not CXCL12.
    van Oosterhout M; Levarht EW; Sont JK; Huizinga TW; Toes RE; van Laar JM
    Ann Rheum Dis; 2005 Apr; 64(4):537-43. PubMed ID: 15769913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comment on 'Drug-related pulmonary problems in patients with rheumatoid arthritis'.
    Yazici Y; Yazici H
    Rheumatology (Oxford); 2007 Feb; 46(2):371-2; author reply 372-3. PubMed ID: 17158808
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment for rheumatoid arthritis and the risk of hospitalization for pneumonia: associations with prednisone, disease-modifying antirheumatic drugs, and anti-tumor necrosis factor therapy.
    Wolfe F; Caplan L; Michaud K
    Arthritis Rheum; 2006 Feb; 54(2):628-34. PubMed ID: 16447241
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Infusion reaction to infliximab in a patient with rheumatoid arthritis after discontinuation over 1 year and readministration.
    Toki H; Momohara S; Tsukahara S; Ikari K
    J Rheumatol; 2008 Sep; 35(9):1896-7; author reply 1897. PubMed ID: 18785300
    [No Abstract]   [Full Text] [Related]  

  • 29. Pulmonary complications of infliximab therapy in patients with rheumatoid arthritis.
    Ostör AJ; Chilvers ER; Somerville MF; Lim AY; Lane SE; Crisp AJ; Scott DG
    J Rheumatol; 2006 Mar; 33(3):622-8. PubMed ID: 16511933
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Response to pneumococcal vaccine in patients with early rheumatoid arthritis receiving infliximab plus methotrexate or methotrexate alone.
    Visvanathan S; Keenan GF; Baker DG; Levinson AI; Wagner CL
    J Rheumatol; 2007 May; 34(5):952-7. PubMed ID: 17444589
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Decrease of anti-cyclic citrullinated peptide antibodies and rheumatoid factor following anti-TNFalpha therapy (infliximab) in rheumatoid arthritis is associated with clinical improvement.
    Alessandri C; Bombardieri M; Papa N; Cinquini M; Magrini L; Tincani A; Valesini G
    Ann Rheum Dis; 2004 Oct; 63(10):1218-21. PubMed ID: 15361374
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cyclosporine in addition to infliximab and methotrexate in refractory rheumatoid arthritis.
    Marchesoni A; Sarzi Puttini P; Gorla R; Caporali R; Arnoldi C; Atzeni F; Vianelli M; Pallavicini FB
    Clin Exp Rheumatol; 2005; 23(6):916-7. PubMed ID: 16396721
    [No Abstract]   [Full Text] [Related]  

  • 33. Pneumonitis induced by methotrexate in a patient with seronegative rheumatoid arthritis.
    Fernández Matilla M; Fernández-Llanio Comella N; Castellano Cuesta JA
    Reumatol Clin; 2015; 11(3):190-1. PubMed ID: 25631247
    [No Abstract]   [Full Text] [Related]  

  • 34. Reducing the risk of methotrexate pneumonitis in rheumatoid arthritis.
    Clewes AR; Dawson JK
    Rheumatology (Oxford); 2004 Aug; 43(8):1059-60; author reply 1060. PubMed ID: 15258299
    [No Abstract]   [Full Text] [Related]  

  • 35. Postmarketing surveillance of the safety profile of infliximab in 5000 Japanese patients with rheumatoid arthritis.
    Takeuchi T; Tatsuki Y; Nogami Y; Ishiguro N; Tanaka Y; Yamanaka H; Kamatani N; Harigai M; Ryu J; Inoue K; Kondo H; Inokuma S; Ochi T; Koike T
    Ann Rheum Dis; 2008 Feb; 67(2):189-94. PubMed ID: 17644554
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [A case of rheumatoid arthritis complicated with methotrexate-induced pneumonitis and pneumocystis pneumonia].
    Minagawa S; Takayanagi N; Hara K; Takaku Y; Tsutiya Y; Hijikata N; Yamaji T; Tokunaga D; Saito H; Ubukata M; Kurashima K; Yanagisawa T; Sugita Y; Kawabata Y
    Nihon Kokyuki Gakkai Zasshi; 2008 Mar; 46(3):237-42. PubMed ID: 18409573
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Hodgkin's disease following methotrexate therapy for rheumatoid arthritis.
    Jardine DL; Colls BM
    N Z Med J; 2002 Jun; 115(1156):293-4. PubMed ID: 12199007
    [No Abstract]   [Full Text] [Related]  

  • 38. Reducing methotrexate errors.
    Zarowitz BJ
    Geriatr Nurs; 2010; 31(5):361-4. PubMed ID: 20832909
    [No Abstract]   [Full Text] [Related]  

  • 39. Nodulosis during methotrexate therapy for rheumatoid arthritis.
    Das SK; Kumar A
    J Assoc Physicians India; 1995 Sep; 43(9):651. PubMed ID: 8773077
    [No Abstract]   [Full Text] [Related]  

  • 40. Early and late effect of infliximab on circulating dendritic cells phenotype in rheumatoid arthritis patients.
    Balanescu A; Radu E; Nat R; Regalia T; Bojinca V; Ionescu R; Balanescu S; Savu C; Predeteanu D
    Int J Clin Pharmacol Res; 2005; 25(1):9-18. PubMed ID: 15864873
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.